256 related articles for article (PubMed ID: 9618311)
1. Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors.
Ramsey WJ; Caplen NJ; Li Q; Higginbotham JN; Shah M; Blaese RM
Biochem Biophys Res Commun; 1998 May; 246(3):912-9. PubMed ID: 9618311
[TBL] [Abstract][Full Text] [Related]
2. Adeno-retroviral chimeric viruses as in vivo transducing agents.
Caplen NJ; Higginbotham JN; Scheel JR; Vahanian N; Yoshida Y; Hamada H; Blaese RM; Ramsey WJ
Gene Ther; 1999 Mar; 6(3):454-9. PubMed ID: 10435096
[TBL] [Abstract][Full Text] [Related]
3. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
[TBL] [Abstract][Full Text] [Related]
5. Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses.
Torrent C; Jullien C; Klatzmann D; Perricaudet M; Yeh P
Cancer Gene Ther; 2000 Aug; 7(8):1135-44. PubMed ID: 10975674
[TBL] [Abstract][Full Text] [Related]
6. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers.
Xu L; Tsuji K; Mostowski H; Otsu M; Candotti F; Rosenberg AS
J Virol Methods; 2004 Jun; 118(1):61-7. PubMed ID: 15158069
[TBL] [Abstract][Full Text] [Related]
7. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression.
Wildner O; Candotti F; Krecko EG; Xanthopoulos KG; Ramsey WJ; Blaese RM
Gene Ther; 1998 May; 5(5):684-91. PubMed ID: 9797874
[TBL] [Abstract][Full Text] [Related]
8. A defective retroviral vector encoding human interferon-alpha2 can transduce human leukemic cell lines.
Austruy E; Bagnis C; Carbuccia N; Maroc C; Birg F; Dubreuil P; Mannoni P; Chabannon C
Cancer Gene Ther; 1998; 5(4):247-56. PubMed ID: 9694076
[TBL] [Abstract][Full Text] [Related]
9. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
Tolmachov O
Med Hypotheses; 2006; 67(4):807-9. PubMed ID: 16759811
[TBL] [Abstract][Full Text] [Related]
10. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector.
Feng M; Jackson WH; Goldman CK; Rancourt C; Wang M; Dusing SK; Siegal G; Curiel DT
Nat Biotechnol; 1997 Sep; 15(9):866-70. PubMed ID: 9306401
[TBL] [Abstract][Full Text] [Related]
11. Detection of osteoclastic cell-cell fusion through retroviral vector packaging.
Kondo T; Ikeda K; Matsuo K
Bone; 2004 Nov; 35(5):1120-6. PubMed ID: 15542037
[TBL] [Abstract][Full Text] [Related]
12. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.
Bauer G; Sauter S; Ibanez C; Rice CR; Valdez P; Jolly D; Kohn DB
Biol Blood Marrow Transplant; 1998; 4(3):119-27. PubMed ID: 9923409
[TBL] [Abstract][Full Text] [Related]
13. [Packaging and concentrating of high titer of retrovirus containing IL-4RA].
Wang GL; Liu XT; Lu JR
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Sep; 11(9):761-4. PubMed ID: 19755029
[TBL] [Abstract][Full Text] [Related]
14. Construction of new retroviral producer cells from adenoviral and retroviral vectors.
Lin X
Gene Ther; 1998 Sep; 5(9):1251-8. PubMed ID: 9930327
[TBL] [Abstract][Full Text] [Related]
15. Generation of high-titer retroviral vectors following receptor-mediated, adenovirus-augmented transfection.
von RĂ¼den T; Stingl L; Cotten M; Wagner E; Zatloukal K
Biotechniques; 1995 Mar; 18(3):484-9. PubMed ID: 7779400
[TBL] [Abstract][Full Text] [Related]
16. Post-mitotic, differentiated myotubes efficiently produce retroviral vector from hybrid adeno-retrovirus templates.
Roberts ML; Athanasopoulos T; Pohlschmidt M; Duisit G; Cosset FL; Dickson G
Gene Ther; 2001 Oct; 8(20):1580-6. PubMed ID: 11704819
[TBL] [Abstract][Full Text] [Related]
17. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
18. Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research.
Chen J; Reeves L; Sanburn N; Croop J; Williams DA; Cornetta K
Virology; 2001 Mar; 282(1):186-97. PubMed ID: 11259201
[TBL] [Abstract][Full Text] [Related]
19. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
20. A novel human suspension culture packaging cell line for production of high-titre retroviral vectors.
Chan LM; Coutelle C; Themis M
Gene Ther; 2001 May; 8(9):697-703. PubMed ID: 11406764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]